Identification of monocyte-like precursors of granulocytes in cancer as a mechanism for accumulation of PMN-MDSCs
Open accessThe DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
We have identified a precursor that differentiates into granulocytes in vitro and in vivo yet belongs to the monocytic lineage. We have termed these cells monocyte-like precursors of granulocytes (MLPGs). Under steady state conditions, MLPGs were absent in the spleen and barely detectable in the bone marrow (BM). In contrast, these cells significantly expanded in tumor-bearing mice and differentiated to polymorphonuclear myeloid-derived suppressor cells (PMN-MDSCs). Selective depletion of monocytic cells had no effect on the number of granulocytes in naive mice but decreased the population of PMN-MDSCs in tumor-bearing mice by 50%. The expansion of MLPGs was found to be controlled by the down-regulation of Rb1, but not IRF8, which is known to regulate the expansion of PMN-MDSCs from classic granulocyte precursors. In cancer patients, putative MLPGs were found within the population of CXCR1+CD15−CD14+HLA-DR−/lo monocytic cells. These findings describe a mechanism of abnormal myelopoiesis in cancer and suggest potential new approaches for selective targeting of MDSCs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures











Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“S100hi monocytes (CD14 +S100hiHLAlo), which showed high expression of alarmins S100A8/A9/A12, TLR4 signaling pathways and low expression of MHC-II genes, characteristic of an M-MDSC signature14, and showed higher expression of the M-MDSC gene signature15 compared with other monocyte subtypes (Fig. 2e and Extended Data Table 2).”
From Single-cell atlas of human liver and blood immune cells across fatty liver disease stages reveals distinct signatures linked to liver dysfunction and fibrogenesis (2025) · cites this paper as [15]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“M-MDSCs have been shown to differentiate into immunosuppressive S100A9+ macrophages (which could be profibrotic) through persistent expression of S100A9 (ref. 15)”
From Single-cell atlas of human liver and blood immune cells across fatty liver disease stages reveals distinct signatures linked to liver dysfunction and fibrogenesis (2025) · cites this paper as [15]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Persistent expression of S100A9 in M-MDSC-derived macrophages was reported to regulate their suppressive activity via the transcription factor CEBPB15”
From Single-cell atlas of human liver and blood immune cells across fatty liver disease stages reveals distinct signatures linked to liver dysfunction and fibrogenesis (2025) · cites this paper as [15]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106 · cited 2×
“DESeq2 (Love et al., 2014)”
RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome
Li, B., & Dewey, C. N. (2011) · BMC Bioinformatics · doi:10.1186/1471-2105-12-323 · Cited by 22,179 · cited 1×
“2.12 software (Li and Dewey, 2011) against mm10 genome and gene-level read counts, and reads per kilobase of transcript per million mapped read values on gene level were estimated for ensemble transcriptome.”
InfluentialStatistical significance for genomewide studies
Storey, J. D., & Tibshirani, R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1530509100 · Cited by 9,692 · cited 1×
“Expression level comparisons between two groups were done using two-sample significance analysis of microarrays (SAM; Zhang, 2007), and correction for multiple testing to estimate FDR was done as described (Storey and Tibshirani, 2003), with FDR <5% used as a significance threshold.”
Improved survival with vemurafenib in melanoma with BRAF V600E mutation
Chapman, P. B., Hauschild, A., Robert, C., Haanen, J. B., Ascierto, P., Larkin, J., Dummer, R., Garbe, C., Testori, A., Maio, M., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1103782 · Cited by 7,720 · cited 1×
“MDSCs are directly implicated in negatively impacting patient responses to cancer therapies (Diaz-Montero et al., 2009; Arihara et al., 2013; Chen et al., 2014; Kawano et al., 2015; Romano et al., 2015; Lee et al., 2016; Tada et al., 2016; Wang et al., 2016; Wang and Yang, 2016), including…”
BackgroundFerroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease
Stockwell, B. R., Friedmann Angeli, J. P., Bayir, H., Bush, A. I., Conrad, M., Dixon, S. J., Fulda, S., Gascón, S., Hatzios, S. K., Kagan, V. E., et al. (2017) · Cell · doi:10.1016/j.cell.2017.09.021 · Cited by 7,695 · cited 1×
“To better characterize CD11b+Ly6G−Ly6Cint cells, we used the CCR2 marker of mature monocytes and the SiglecF marker of eosinophils/neutrophils (Stockwell et al., 2017).”
MethodCoordinated regulation of myeloid cells by tumours
Gabrilovich, D. I., Ostrand-Rosenberg, S., & Bronte, V. (2012) · Nature Reviews Immunology · doi:10.1038/nri3175 · Cited by 3,544 · cited 1×
“There is now ample evidence suggesting that the success of cancer immunotherapies and even more traditional methods of treatment, such as radiation and chemotherapy, heavily depend on myeloid cells in the tumor microenvironment (Coussens and Pollard, 2011; Galdiero et al., 2013).”
BackgroundSelf-citationMechanism of Activation of the RAF-ERK Signaling Pathway by Oncogenic Mutations of B-RAF
Wan, P. T. C., Garnett, M. J., Roe, S. M., Lee, S., Niculescu-Duvaz, D., Good, V. M., Project, C. G., Jones, C. M., Marshall, C. J., Springer, C. J., et al. (2004) · Cell · doi:10.1016/s0092-8674(04)00215-6 · Cited by 2,808 · cited 1×
“Data were aligned using bowtie2 (Wan et al., 2004) and RSEM v1.”
MethodRecommendations for myeloid-derived suppressor cell nomenclature and characterization standards
Bronte, V., Brandau, S., Chen, S.-H., Colombo, M. P., Frey, A. B., Greten, T. F., Mandruzzato, S., Murray, P. J., Ochoa, A., Ostrand-Rosenberg, S., et al. (2016) · Nature Communications · doi:10.1038/ncomms12150 · Cited by 2,751
Self-citationA clonogenic common myeloid progenitor that gives rise to all myeloid lineages
Akashi, K., Traver, D., Miyamoto, T., & Weissman, I. L. (2000) · Nature · doi:10.1038/35004599 · Cited by 2,617
Prostate cancer in a transgenic mouse.
Greenberg, N. M., DeMayo, F., Finegold, M. J., Medina, D., Tilley, W. D., Aspinall, J. O., Cunha, G. R., Donjacour, A. A., Matusik, R. J., & Rosen, J. M. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.8.3439 · Cited by 1,294 · cited 2×
“Mastio et al. Journal of Experimental Medicine 2158 Monocytic precursors of granulocytes in cancer https://doi.org/10.1084/jem.20181952 important role in the switch between monocytic and granulocytic differentiation (Holtschke et al., 1996;Wang et al., 2014).”
BackgroundMethodInfluentialDiaz-Montero, C. M., Salem, M. L., Nishimura, M. I., Garrett-Mayer, E., Cole, D. J., & Montero, A. J. (2009) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-008-0523-4 · Cited by 1,215
Bayne, L. J., Beatty, G. L., Jhala, N., Clark, C. E., Rhim, A. D., Stanger, B. Z., & Vonderheide, R. H. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.04.025 · Cited by 947
Self-citationSchug, Z. T., Peck, B., Jones, D. T., Zhang, Q., Grosskurth, S., Alam, I. S., Goodwin, L. M., Smethurst, E., Mason, S., Blyth, K., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2014.12.002 · Cited by 820 · cited 1×
“, 2015), whereas in several other studies splenectomy was performed at the time of tumor inoculation (Lecut et al., 2009; Schug et al., 2015).”
Evrard, M., Kwok, I. W. H., Chong, S. Z., Teng, K. W. W., Becht, E., Chen, J., Sieow, J. L., Penny, H. L., Ching, G. C., Devi, S., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.02.002 · Cited by 705 · cited 1×
“The current prevailing view is that M-MDSCs and PMN-MDSCs differentiate along the same pathways as monocytes and neutrophils, respectively, and their expansion in cancer is controlled by increased production of GM-CSF, CSF-1, and other growth factors (Gabrilovich et al., 2012).”
BackgroundHoltschke, T., Löhler, J., Kanno, Y., Fehr, T., Giese, N., Rosenbauer, F., Lou, J., Knobeloch, K.-P., Gabriele, L., Waring, J. F., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81348-3 · Cited by 644 · cited 1×
“In addition, the Ret melanoma (Kato et al., 1998), transgenic adenocarcinoma mouse prostate (TRAMP) prostate (Greenberg et al., 1995), and KrasG12DTrp53R172HPdx-1 (KPC) pancreatic (Bayne et al., 2012) GEMs were used.”
MethodMartens, A., Wistuba-Hamprecht, K., Foppen, M. G., Yuan, J., Postow, M. A., Wong, P., Romano, E., Khammari, A., Dreno, B., Capone, M., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-2412 · Cited by 541 · cited 1×
“, 2016; Wang and Yang, 2016), including immunotherapies (Kimura et al., 2013; Martens et al., 2016; Sade-Feldman et al., 2016; Weber et al., 2016; Butterfield et al., 2017; de Coaña et al., 2017).”
Regulation of Tumor Metastasis by Myeloid-Derived Suppressor Cells
Condamine, T., Ramachandran, I., Youn, J.-I., & Gabrilovich, D. I. (2015) · Annual Review of Medicine · doi:10.1146/annurev-med-051013-052304 · Cited by 521 · cited 1×
“There is now ample evidence suggesting that the success of cancer immunotherapies and even more traditional methods of treatment, such as radiation and chemotherapy, heavily depend on myeloid cells in the tumor microenvironment (Coussens and Pollard, 2011; Galdiero et al., 2013).”
BackgroundSelf-citationYoun, J.-I., Collazo, M., Shalova, I. N., Biswas, S. K., & Gabrilovich, D. I. (2011) · Journal of Leukocyte Biology · doi:10.1189/jlb.0311177 · Cited by 510 · cited 1×
“We compared the expression profile of MLPGs and GPs with populations of BM and spleen CD11b+Ly6CintLy6G+ neutrophils/PMN-MDSCs and CD11b+Ly6ChiLy6G− monocytes/M-MDSCs isolated from naive and EL4-TB mice that have been characterized previously (Youn et al., 2012).”
Self-citationCasbon, A.-J., Reynaud, D., Park, C., Khuc, E., Gan, D. D., Schepers, K., Passegué, E., & Werb, Z. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1424927112 · Cited by 470 · cited 2×
“These pathways involve pluripotent hematopoietic stem cells, multipotent common myeloid progenitors (CMPs), and granulocyte-macrophage progenitors ............................................................................................................................................................................…”
MethodYáñez, A., Coetzee, S. G., Olsson, A., Muench, D. E., Berman, B. P., Hazelett, D. J., Salomonis, N., Grimes, H. L., & Goodridge, H. S. (2017) · Immunity · doi:10.1016/j.immuni.2017.10.021 · Cited by 470 · cited 4×
“Interestingly monocytes derived from GMPs had expression of genes specific for neutrophils (Yáñez et al., 2017).”
BackgroundInfluentialTumor associated macrophages and neutrophils in tumor progression
Galdiero, M. R., Garlanda, C., Jaillon, S., Marone, G., & Mantovani, A. (2013) · Journal of Cellular Physiology · doi:10.1002/jcp.24260 · Cited by 440 · cited 1×
“In addition, the Ret melanoma (Kato et al., 1998), transgenic adenocarcinoma mouse prostate (TRAMP) prostate (Greenberg et al., 1995), and KrasG12DTrp53R172HPdx-1 (KPC) pancreatic (Bayne et al., 2012) GEMs were used.”
MethodYoun, J.-I., Kumar, V., Collazo, M., Nefedova, Y., Condamine, T., Cheng, P., Villagra, A., Antonia, S., McCaffrey, J. C., Fishman, M., et al. (2013) · Nature Immunology · doi:10.1038/ni.2526 · Cited by 350 · cited 2×
“Transgenic KPC mice (Bayne et al., 2012), Rb1 KO (Youn et al., 2013), and Rb TKO (Viatour et al., 2008) mice were described previously.”
Self-citationMyeloid-derived suppressor cell development is regulated by a STAT/IRF-8 axis
Waight, J. D., Netherby, C., Hensen, M. L., Miller, A., Hu, Q., Liu, S., Bogner, P. N., Farren, M. R., Lee, K. P., Liu, K., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci68189 · Cited by 323 · cited 2×
“Recently, several populations of committed granulocytic precursors (GPs) were identified (Waight et al., 2013; Y´añez et al., 2015; Evrard et al., 2018).”
Self-citationRb regulates fate choice and lineage commitment in vivo
Calo, E., Quintero-Estades, J. A., Danielian, P. S., Nedelcu, S., Berman, S. D., & Lees, J. A. (2010) · Nature · doi:10.1038/nature09264 · Cited by 314 · cited 1×
“The concept of Rb1 involvement in PMN-MDSC differentiation was supported in more recent studies using a breast cancer mouse model (Casbon et al., 2015).”
ResultKimura, T., McKolanis, J. R., Dzubinski, L. A., Islam, K., Potter, D. M., Salazar, A. M., Schoen, R. E., & Finn, O. J. (2013) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-12-0275 · Cited by 263 · cited 8×
“It is known that the IRF8 transcription factor plays an Figure 5.”
BackgroundInfluentialArihara, F., Mizukoshi, E., Kitahara, M., Takata, Y., Arai, K., Yamashita, T., Nakamoto, Y., & Kaneko, S. (2013) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-013-1447-1 · Cited by 252
Weber, J., Gibney, G., Kudchadkar, R., Yu, B., Cheng, P., Martinez, A. J., Kroeger, J., Richards, A., McCormick, L., Moberg, V., et al. (2016) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-15-0193 · Cited by 248 · cited 1×
“, 2016; Wang and Yang, 2016), including immunotherapies (Kimura et al., 2013; Martens et al., 2016; Sade-Feldman et al., 2016; Weber et al., 2016; Butterfield et al., 2017; de Coaña et al., 2017).”
Transgenic mouse model for skin malignant melanoma
Kato, M., Takahashi, M., Akhand, A. A., Liu, W., Dai, Y., Shimizu, S., Iwamoto, T., Suzuki, H., & Nakashima, I. (1998) · Oncogene · doi:10.1038/sj.onc.1202077 · Cited by 218 · cited 3×
“Previous studies demonstrated that splenectomy reduced the presence of MDSCs in tumors (Lecut et al., 2009; Kawano et al., 2015; Levy et al., 2015; Schug et al., 2015).”
BackgroundMethodLeukocytes in Mammary Development and Cancer
Coussens, L. M., & Pollard, J. W. (2011) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a003285 · Cited by 208
Sade-Feldman, M., Kanterman, J., Klieger, Y., Ish-Shalom, E., Olga, M., Saragovi, A., Shtainberg, H., Lotem, M., & Baniyash, M. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-3104 · Cited by 201 · cited 1×
“…al., 2014; Kawano et al., 2015; Romano et al., 2015; Lee et al., 2016; Tada et al., 2016; Wang et al., 2016; Wang and Yang, 2016), including immunotherapies (Kimura et al., 2013; Martens et al., 2016; Sade-Feldman et al., 2016; Weber et al., 2016; Butterfield et al., 2017; de Coaña et al., 2017).”
BackgroundViatour, P., Somervaille, T. C., Venkatasubrahmanyam, S., Kogan, S., McLaughlin, M. E., Weissman, I. L., Butte, A. J., Passegué, E., & Sage, J. (2008) · Cell Stem Cell · doi:10.1016/j.stem.2008.07.009 · Cited by 178 · cited 4×
“Transgenic KPC mice (Bayne et al., 2012), Rb1 KO (Youn et al., 2013), and Rb TKO (Viatour et al., 2008) mice were described previously.”
InfluentialSelf-citationKurotaki, D., Yamamoto, M., Nishiyama, A., Uno, K., Ban, T., Ichino, M., Sasaki, H., Matsunaga, S., Yoshinari, M., Ryo, A., et al. (2014) · Nature Communications · doi:10.1038/ncomms5978 · Cited by 176 · cited 2×
“Previous studies demonstrated that splenectomy reduced the presence of MDSCs in tumors (Lecut et al., 2009; Kawano et al., 2015; Levy et al., 2015; Schug et al., 2015).”
BackgroundMethodThe discovery of vemurafenib for the treatment of BRAF-mutated metastatic melanoma
Kim, A., & Cohen, M. S. (2016) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2016.1201057 · Cited by 169
Chen, M.-F., Kuan, F.-C., Yen, T.-C., Lu, M.-S., Lin, P.-Y., Chung, Y.-H., Chen, W.-C., & Lee, K.-D. (2014) · Oncotarget · doi:10.18632/oncotarget.2368 · Cited by 155 · cited 1×
“Besides suppressing antitumor immunity, MDSCs also stimulate other aspects of tumor growth including tumor angiogenesis, tumor cell invasion, and formation of premetastatic niches (Condamine et al., 2015).”
BackgroundKawano, M., Mabuchi, S., Matsumoto, Y., Sasano, T., Takahashi, R., Kuroda, H., Kozasa, K., Hashimoto, K., Isobe, A., Sawada, K., et al. (2015) · Scientific Reports · doi:10.1038/srep18217 · Cited by 145 · cited 1×
“Two-dimensional clustering was done using t-distributed stochastic neighbor embedding (tSNE; Kim and Cohen, 2016).”
Methodde Coaña, Y. P., Wolodarski, M., Poschke, I., Yoshimoto, Y., Yang, Y., Nyström, M., Edbäck, U., Brage, S. E., Lundqvist, A., Masucci, G. V., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.15368 · Cited by 139 · cited 1×
“MDSCs are directly implicated in negatively impacting patient responses to cancer therapies (Diaz-Montero et al., 2009; Arihara et al., 2013; Chen et al., 2014; Kawano et al., 2015; Romano et al., 2015; Lee et al., 2016; Tada et al., 2016; Wang et al., 2016; Wang and Yang, 2016), including…”
BackgroundYáñez, A., Ng, M. Y., Hassanzadeh-Kiabi, N., & Goodridge, H. S. (2015) · Blood · doi:10.1182/blood-2014-09-600833 · Cited by 131 · cited 2×
“A previous study identified a population of Ly6C + CD117 + LKS − CD34 + Fc γ R hi cells as committed granulocytic progenitors (Y´añez et al., 2015).”
P2X1 Ion Channels Promote Neutrophil Chemotaxis through Rho Kinase Activation
Lecut, C., Frederix, K., Johnson, D. M., Deroanne, C., Thiry, M., Faccinetto, C., Marée, R., Evans, R. J., Volders, P. G. A., Bours, V., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0804007 · Cited by 112 · cited 2×
“Previous studies demonstrated that splenectomy reduced the presence of MDSCs in tumors (Lecut et al., 2009; Kawano et al., 2015; Levy et al., 2015; Schug et al., 2015).”
Romano, A., Parrinello, N. L., Vetro, C., Forte, S., Chiarenza, A., Figuera, A., Motta, G., Palumbo, G. A., Ippolito, M., Consoli, U., et al. (2015) · British Journal of Haematology · doi:10.1111/bjh.13198 · Cited by 94 · cited 2×
“…negatively impacting patient responses to cancer therapies (Diaz-Montero et al., 2009; Arihara et al., 2013; Chen et al., 2014; Kawano et al., 2015; Romano et al., 2015; Lee et al., 2016; Tada et al., 2016; Wang et al., 2016; Wang and Yang, 2016), including immunotherapies (Kimura et al., 2013;…”
BackgroundNetherby, C. S., Messmer, M. N., Burkard-Mandel, L., Colligan, S., Miller, A., Cortes Gomez, E., Wang, J., Nemeth, M. J., & Abrams, S. I. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601722 · Cited by 77 · cited 1×
“Down-regulation of the IRF8 transcription factor, which is important for the switch between monocytic and granulocytic cell differentiation (Kurotaki et al., 2014), was directly implicated in the expansion of PMN-MDSCs from GPs (Netherby et al., 2017).”
Self-citationTada, K., Kitano, S., Shoji, H., Nishimura, T., Shimada, Y., Nagashima, K., Aoki, K., Hiraoka, N., Honma, Y., Iwasa, S., et al. (2016) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-15-0298 · Cited by 76 · cited 2×
“MDSCs are directly implicated in negatively impacting patient responses to cancer therapies (Diaz-Montero et al., 2009; Arihara et al., 2013; Chen et al., 2014; Kawano et al., 2015; Romano et al., 2015; Lee et al., 2016; Tada et al., 2016; Wang et al., 2016; Wang and Yang, 2016), including immunotherapies (Kimura et a…”
BackgroundZhang, S. (2007) · BMC Bioinformatics · doi:10.1186/1471-2105-8-230 · Cited by 75 · cited 1×
“Expression level comparisons between two groups were done using two-sample significance analysis of microarrays (SAM; Zhang, 2007), and correction for multiple testing to estimate FDR was done as described (Storey and Tibshirani, 2003), with FDR <5% used as a significance threshold.”
Wang, D., An, G., Xie, S., Yao, Y., & Feng, G. (2016) · Tumor Biology · doi:10.1007/s13277-016-4916-2 · Cited by 74 · cited 1×
“…(Diaz-Montero et al., 2009; Arihara et al., 2013; Chen et al., 2014; Kawano et al., 2015; Romano et al., 2015; Lee et al., 2016; Tada et al., 2016; Wang et al., 2016; Wang and Yang, 2016), including immunotherapies (Kimura et al., 2013; Martens et al., 2016; Sade-Feldman et al., 2016; Weber et…”
BackgroundWang, H., Yan, M., Sun, J., Jain, S., Yoshimi, R., Abolfath, S. M., Ozato, K., Coleman, W. G., Ng, A. P., Metcalf, D., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1301939 · Cited by 72 · cited 1×
“It is known that the IRF8 transcription factor plays an important role in the switch between monocytic and granulocytic differentiation (Holtschke et al., 1996; Wang et al., 2014).”
Levy, L., Mishalian, I., Bayuch, R., Zolotarov, L., Michaeli, J., & Fridlender, Z. G. (2015) · OncoImmunology · doi:10.1080/2162402x.2014.998469 · Cited by 61 · cited 1×
“2.12 software (Li and Dewey, 2011) against mm10 genome and genelevel read counts, and reads per kilobase of transcript per million mapped read values on gene level were estimated for ensemble transcriptome.”
MethodInfluentialButterfield, L. H., Zhao, F., Lee, S., Tarhini, A. A., Margolin, K. A., White, R. L., Atkins, M. B., Cohen, G. I., Whiteside, T. L., Kirkwood, J. M., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-3016 · Cited by 61
Targeting Myeloid-Derived Suppressor Cells in Cancer
Anani, W. Q., & Shurin, M. R. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-67577-0_8 · Cited by 59
Interferon regulatory factor‐8 modulates the development of tumour‐induced CD11b+Gr‐1+ myeloid cells
Stewart, T. J., Greeneltch, K. M., Reid, J. E., Liewehr, D. J., Steinberg, S. M., Liu, K., & Abrams, S. I. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00685.x · Cited by 52 · cited 1×
“Its down-regulation was previously implicated in the accumulation of PMN-MDSCs (Stewart et al., 2009; Waight et al., 2013; Paschall et al., 2015).”
Self-citationPaschall, A. V., Zhang, R., Qi, C.-F., Bardhan, K., Peng, L., Lu, G., Yang, J., Merad, M., McGaha, T., Zhou, G., et al. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402412 · Cited by 52 · cited 1×
“Its down-regulation was previously implicated in the accumulation of PMN-MDSCs (Stewart et al., 2009; Waight et al., 2013; Paschall et al., 2015).”
Self-citationRegulation of RB Transcription In Vivo by RB Family Members
Burkhart, D. L., Ngai, L. K., Roake, C. M., Viatour, P., Thangavel, C., Ho, V. M., Knudsen, E. S., & Sage, J. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.00952-09 · Cited by 50
Self-citationWang, J., & Yang, J. (2016) · Biomedical Reports · doi:10.3892/br.2016.694 · Cited by 28 · cited 2×
“…(Diaz-Montero et al., 2009; Arihara et al., 2013; Chen et al., 2014; Kawano et al., 2015; Romano et al., 2015; Lee et al., 2016; Tada et al., 2016; Wang et al., 2016; Wang and Yang, 2016), including immunotherapies (Kimura et al., 2013; Martens et al., 2016; Sade-Feldman et al., 2016; Weber et…”
Lee, S., Lim, J., Ryu, D., Kim, T., Yoon, J., Cho, B., Eom, K., Kim, Y., Kim, H., Lee, S., et al. (2016) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-016-1861-2 · Cited by 27 · cited 2×
“Previous studies demonstrated that splenectomy reduced the presence of MDSCs in tumors (Lecut et al., 2009; Kawano et al., 2015; Levy et al., 2015; Schug et al., 2015).”
Background
Cited by
Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity
Veglia, F., Sanseviero, E., & Gabrilovich, D. I. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-020-00490-y · Cited by 1,940
Self-citationElevated Calprotectin and Abnormal Myeloid Cell Subsets Discriminate Severe from Mild COVID-19
Silvin, A., Chapuis, N., Dunsmore, G., Goubet, A.-G., Dubuisson, A., Derosa, L., Almire, C., Hénon, C., Kosmider, O., Droin, N., et al. (2020) · Cell · doi:10.1016/j.cell.2020.08.002 · Cited by 834
MDSC: Markers, development, states, and unaddressed complexity
Hegde, S., Leader, A. M., & Merad, M. (2021) · Immunity · doi:10.1016/j.immuni.2021.04.004 · Cited by 669
Myeloid-derived suppressor cells in cancer and cancer therapy
Lasser, S. A., Ozbay Kurt, F. G., Arkhypov, I., Utikal, J., & Umansky, V. (2024) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-023-00846-y · Cited by 489
Myeloid-derived suppressor cells: an emerging target for anticancer immunotherapy
Wu, Y., Yi, M., Niu, M., Mei, Q., & Wu, K. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01657-y · Cited by 458
“Intriguingly, a recent study identified a new group of monocyte lineage precursors that differentiated into a substantial subset of PMN-MDSCs, and they were designated as monocyte-like precursors of granulocytes (MLPGs) [15].”
Background
Metadata
- Authors
- Mastio, J., Condamine, T., Dominguez, G., Kossenkov, A. V., Donthireddy, L., Veglia, F., Lin, C., Wang, F., Fu, S., Zhou, J., Viatour, P., Lavilla-Alonso, S., Polo, A. T., Tcyganov, E. N., Mulligan, C., Nam, B., Bennett, J., Masters, G., Guarino, M., Kumar, A., Nefedova, Y., Vonderheide, R. H., Languino, L. R., Abrams, S. I., & Gabrilovich, D. I.
- Affiliations
- The Wistar Institute (US)
- Sun Yat-sen University (CN)
- University of Pennsylvania (US)
- Asociación Demográfica Costarricense (CR)
- Christiana Care Health System (US)
- Thomas Jefferson University (US)
- Roswell Park Comprehensive Cancer Center (US)
- Corresponding author
- Gabrilovich, Dmitry I.
- ORCID
- Mastio, Jérôme
- Condamine, Thomas
- Dominguez, George
- Kossenkov, Andrew V.
- Donthireddy, Laxminarasimha
- Veglia, Filippo
- Lin, Cindy
- Wang, Fang
- Fu, Shuyu
- Zhou, Jie
- Viatour, Patrick
- Tcyganov, Evgenii N.
- Mulligan, Charles
- Nam, Brian
- Bennett, Joseph
- Masters, Gregory
- Kumar, Amit
- Nefedova, Yulia
- Vonderheide, Robert H.
- Languino, Lucia R.
- Abrams, Scott I.
- Gabrilovich, Dmitry I.
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2019-06-25
- Volume
- 216
- Issue
- 9
- Pages
- 2150-2169
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC6719429
- OpenAlex
- W2954317599
- Cited by
- 115
- References
- 52
- Citations by year
- 2026: 5 · 2025: 17 · 2024: 12 · 2023: 22 · 2022: 22 · 2021: 23 · 2020: 10 · 2019: 4
- FWCI
- 5.88
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- The Journal of Experimental Medicine (publishedVersion, cc-by-nc-sa)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- The Medicine Forum (submittedVersion, cc-by-nc-sa)
- Funders
- National Institutes of Health (CA084488, CA140043)
- Wistar Institute Animal and Bioinformatics (P30 CA010815)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Keywords
- polymorphonuclear myeloid-derived suppressor cells, RB1, IRF8, monocytic lineage, granulocytic differentiation, MDSC depletion, tumor immunosuppression
- MeSH terms
- Myeloid-Derived Suppressor Cells, Adult, Aged, Animals, Cell Differentiation, Female, Humans, Male, Mice, Inbred C57BL, Middle Aged, Monocytes, Neoplasms, Neutrophils, Mice, Retinoblastoma Binding Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.